Company Analysis - Merck & Co., Inc.
RNCOS
January 1, 2012 35 Pages - SKU: CICQ6750135
|
|
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is an outcome of extensive research and makes use of data provided by various credible publications, trade journals, industry associations, and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
|
- 1. Company Overview
- 1.1 History
- 1.2 Business Overview
- 1.3 Organizational Structure
- 1.4 Major Mergers & Acquisitions
- 1.5 Ticker Codes at Various Stock Exchange Listings
- 1.6 Management Profile
- 2. Product & Services
- 2.1 Product & Services - An Overview
- 2.2 Revenue Summary by Geographical Distribution
- 2.3 Revenue Summary by Business Division
- 3. Financial Information for the Fiscal Year
- 3.1 Financial Summary for the Fiscal Year
- 3.2 Breakup of Revenue & Sales Trends
- 3.3 Ratio & Market Indicators
- 3.4 Earnings & Income Estimates
- 3.5 Stock Analysis
- 4. SWOT Analysis
- 4.1 Strengths
- 4.2 Weaknesses
- 4.3 Opportunity
- 4.4 Threats
- 5. Top Competitors (Key Financials & SWOT Analysis)
- 5.1 GlaxoSmithKline Plc.
- 5.2 Pfizer Inc.
- 5.3 Abbott Laboratories Ltd.
- 5.4 Eli Lilly & Co.
- 6. Analyst View
- List of Figures:
- Figure 2-1: Merck & Co., Inc. - Revenue by Geographical Distribution (Billion US$), 2009 & 2010
- Figure 2-2: Merck & Co., Inc. - Revenue by Business Division (Billion US$), 2009 & 2010
- Figure 3-1: Merck & Co., Inc. - Stock Chart
- List of Tables:
- Table 1-1: Merck & Co., Inc. - Major Mergers & Acquisitions (1999 to 2011)
- Table 1-2: Merck & Co., Inc. - Ticker Codes at various Stock Exchange
- Table 1-3: Merck & Co., Inc. - Key Management People
- Table 3-1: Merck & Co., Inc. - Financial Overview (Billions US$), 2010
- Table 3-2: Merck & Co., Inc. - Breakup of Revenue & Sales (Billion US$), 2008-2010
- Table 3-3: Merck & Co., Inc. - Key Financial Ratios (2008-2010)
- Table 3-4: Merck & Co., Inc. - Earnings & Income Estimates (Billion US$), 2008-2010
- Table 5-1: GlaxoSmithKline Plc. - Key Financials (Million US$), 2008-2010
- Table 5-2: GlaxoSmithKline Plc. - SWOT Analysis
- Table 5-3: Pfizer Inc. - Key Financials (Million US$), 2008-2010
- Table 5-4: Pfizer Inc. - SWOT Analysis
- Table 5-5: Abbott Laboratories Ltd. - Key Financials (Million US$), 2008-2010
- Table 5-6: Abbott Laboratories Ltd. - SWOT Analysis
- Table 5-7: Eli Lilly & Co. - Key Financials (Million US$), 2008-2010
- Table 5-8: Eli Lilly & Co. - SWOT Analysis
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
